Firefly Neuroscience (AIFF) said Tuesday it has obtained up to $12.4 million in new funding to support the commercialization of the company's Brain Network Analytics technology and for general working capital purposes.
The funding comprises $2.4 million upfront in senior convertible notes at $3 per share, together with an equity line of credit for up to $10 million, the company said.
Firefly Neuroscience shares were nearly 3% higher in recent Tuesday trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.